Stock UniverseDerived research view · source repositories remain read-only

Kazia Therapeutics Limited (KZIA)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
20.47
Global Rank
3300
Market Cap
92.07M
Latest Close
10.99
RS Composite
-2.31% · G#1535

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-20.59%
3M
33.21%
6M
-17.06%
1Y
105.04%
3Y
-81.53%
5Y
-97.69%
10Y
-97.29%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 188.03K · 30-day average: 219.66K · Max drawdown over stored range: -99.58%

Research Snapshot

Relative Strength vs SPX

RS Composite-2.31%
20D RS-18.68%
60D RS26.54%
120D RS-22.97%
Global RS Rank1535 · 54.25% percentile
Watch+Speculative RS Rank981 · 53.22% percentile
Group ScopeWatch+Speculative
Primary RS Rank144 · 68.56% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank446 / 701
Primary Percentile36.52
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for KZIA.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue15.18270.010.0012.4811.829
Revenue Growth (YoY)1436.541%-99.934%-90.0%248000%-26.28%
Gross Profit15.18270.010.0012.4811.829
Operating Income-6.3783-25.384-24.146-28.462-14.217
Free Cash Flow-9.1105-22.762-15.156-9.581-13.278
Free Cash Flow Per Share-38.711-85.915-41.121-18.168-12.116
EPS (Diluted) GAAP-35.799999-94.415611-55.525559-50.778131-18.890719
EPS Growth
EPS Non-GAAP
Gross Margin100%100%100%100%100%
Operating Margin-42.01%-253840.0%-2414600%-1147.199%-777.31%
Profit Margin-55.471%-250140.0%-2046500%-1079.323%-1131.875%
Free Cash Flow Margin-60.006%-227620.0%-1515600%-386.175%-725.97%
Shares Outstanding (Diluted)0.23530.26490.36860.52741.0959
Shares Change (YoY)61.08%12.571%39.117%43.081%107.808%

SEC Quarterly Fundamentals

No processed quarterly rows for KZIA.